ARCHIVES

ODAC Prefers Three-Hour Taxol Infusion. Says Data Dosage Still Uncertain

This article is from The Cancer Letter archive.

Vol. 19 No. 38 | October 1, 1993

Download PDF Visit The Full Archive

Related Articles

Senate Committee Blocks Effort To Overturn Organ Systems Changes

December 10, 1982

Monoclonal Antibody Improves AML Response To Therapy

July 26, 2002

In Brief: Calabresi Named To President’s Cancer Panel; Mays Leaves NCI Technology Office For IVAX

May 5, 1995

Animal Problems May Stop NIC Construction Grant To city Of Hope

September 13, 1985

Pill Associated With Cancer In BRCA1 Mutation Carriers

January 31, 2003

Terry To Leave As DRCCA Acting Director Sept. 1, Peter Greenwald Is DeVita’s Choice For The Job

August 14, 1981